Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Neurocrine Biosciences, Inc.”

110 pharma patents match "Neurocrine Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 110
Index total 30,257
Page 2 / 5

Quick answer

This filtered view shows 110 pharmaceutical patents matching "Neurocrine Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

110 results for “Neurocrine Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 10912771

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  2. US 10905690

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  3. US 10874648

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  4. US 10857137

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  5. US 10857148

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  6. US 10851103

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  7. US 10851104

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  8. US 10844058

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  9. US 10738017

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  10. US 10494347

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  11. US 10336769

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted
  12. US 10138214

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  13. US 10065952

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  14. US 9988382

    [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  15. US 9868706

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted
  16. US 9782398

    Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

    Neurocrine Biosciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  17. US 9718789

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  18. US 9714246

    [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  19. US 9422310

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  20. US 9382214

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  21. US 8952161

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  22. US 8765948

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  23. US 8507536

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  24. US 8481731

    Compounds, pharmaceutical composition and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted